破碎非常规储层微尺度超临界CO泡沫运输的_高压 试验微流体制造技术

Executive Industry Relevance

This work addresses a critical gap in microfluidic platform capabilities by enabling direct visualization of multiphase flow under high-pressure and high-temperature conditions relevant to subsurface reservoirs. The described fabrication techniques provide a pathway for biopharma R&D teams to develop robust lab-on-chip systems for studying complex fluid behavior in surrogate permeable media, supporting mechanistic de-risking in early discovery and assay development workflows. By establishing protocols for chemically and physically resistant microfluidic devices, the study enhances predictive confidence in modeling transport phenomena that inform target validation and preclinical decision-making.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Enables interrogation of therapeutic hypotheses through direct observation of fluid-structure interactions in complex geometries under physiologically relevant pressure conditions.
• Operational Value: Supports biological de-risking by providing reproducible platforms for functional target validation in surrogate systems that mimic in vivo microenvironments.
• Predictive Value: Enhances portfolio triage by generating quantitative data on foam stability and transport dynamics that inform lead identification and mechanistic de-risking.

Screening & Assay Development

• Scientific Value: Prepares validated biological systems for downstream workflows by enabling high-resolution observation of multiphase flow at 10 µm resolution, critical for assay standardization.
• Operational Value: Addresses assay reproducibility and scalability through fabrication techniques that yield chemically resistant devices tolerant of extreme conditions, supporting reliable compound evaluation.
• Platform Reuse: Highlights scalability and platform reuse potential, as both photolithography/wet-etching and SLE techniques produce devices suitable for repeated high-pressure testing cycles.

Translational & Preclinical Research

• Translational Continuity: Discusses disease relevance and translational biomarker alignment by linking scCO₂ foam behavior observations to enhanced oil recovery processes, offering a proxy for studying complex fluid transport in heterogeneous media.
• Risk-Adjusted Advancement: Describes continuity from discovery through preclinical validation by establishing protocols that withstand reservoir-like conditions, enabling risk-adjusted decisions in preclinical model selection.
• Mechanistic De-risking: Focuses on predictive de-risking value when applied mechanistically, as the method clarifies pathway-level interactions in fractured systems under controlled variables.

Pipeline & Workflow Integration

The method integrates into the discovery continuum from Early Discovery through Lead Identification to Preclinical work, supporting hypothesis testing, assay readiness, and quantitative analytics that inform translational continuity and enterprise reuse.

• Discovery Biology: Explains how the method supports hypothesis testing, pathway clarification, and biological de-risking by enabling direct visualization of complex fluid interactions in surrogate permeable media under high pressure.
• Screening: Describes assay readiness, reproducibility, and quantitative outputs through the use of high-resolution monochromatic sensors and image-based analysis of foam microstructure and stability.
• Analytics: Highlights measurements, readouts, and statistical outputs such as bubble diameter distribution via ImageJ, enabling teams to compare conditions and assess foam generation under varying flow rates.
• Translational Research: Connects the method to preclinical continuity by linking observed scCO₂ foam transport to reservoir-scale processes, supporting biomarker alignment in studies of fluid recovery from unconventional formations.
• Enterprise Reuse: Frames the method as a reusable capability rather than a single-use technique, as both fabrication pathways yield devices capable of withstanding repeated high-pressure and thermal cycling.

Operational & Enterprise Impact

• Scientific Value: Predictive confidence, target validation, reduction of mechanistic ambiguity in multiphase flow studies.
• Operational Value: Standardization, reproducibility, and scalability of microfluidic platforms for high-pressure applications.
• Strategic Value: Better go/no-go decisions, capital efficiency, and reduced late-stage biological risk through early-stage mechanistic insights.
• Portfolio Impact: Risk-adjusted prioritization and advancement decisions based on quantitative transport data generated under reservoir-mimicking conditions.

Implementation Considerations

• Required scientific expertise in microfluidic fabrication, photolithography, wet-etching, and thermal bonding processes.
• Instrumentation and analytical infrastructure needs including UV exposure systems, etching solutions, pressure-resistant holders, and high-resolution imaging systems.
• Cross-team standardization requirements for protocol execution across multidisciplinary teams involving chemistry, engineering, and imaging specialists.
• Adaptation considerations across model systems, noting that while optimized for glass substrates and scCO₂ foam, the techniques may require modification for soft biological materials or aqueous-based assays.
• Practical limitations supported by source material: photolithography/wet-etching enables complex channel networks challenging for laser etching, but both techniques require careful handling of hazardous chemicals such as piranha solution and NMP during fabrication.

Biopharma FAQs